Trademark: 90690466
Word
EIKON THERAPEUTICS
Status
Pending
Status Code
732
Status Date
Monday, March 4, 2024
Serial Number
90690466
Mark Type
3000
Filing Date
Tuesday, May 4, 2021
Published for Opposition
Tuesday, August 2, 2022

Trademark Owner History
EIKON THERAPEUTICS, INC. - Owner At Publication

Classifications
42 Pharmaceutical drug discovery and development services; Scientific and medical research, development and information services in the fields of pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicine discovery and development; Drug discovery and pharmaceutical development services for the pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine industries; Providing temporary use of on-line non-downloadable software for tracking and measuring movement of proteins in living cells for drug discovery and development; Providing temporary use of on-line non-downloadable software for tracking and measuring movement of proteins in living cells for pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine discovery and development services; Drug, pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine research and development and testing; Research and development of new products in the fields of drugs, pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicines; Biomedical research and development services in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Medical and clinical research and pharmaceutical development services to discover and develop medicines and vaccines in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Research, development, analysis, testing and consulting services in the fields of biochemistry, biotechnology, medicines, diagnostics, vaccines and pharmaceuticals; Scientific, medical, biological, biotechnology, biomedical, pharmaceutical research, development, analysis and testing services in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Scientific laboratory services, namely, live cell imaging analysis; Custom design and development of cells, cell lines and assays; Biomedical research services using a platform of biological tools and techniques for use in scientific research, drug and vaccine discovery and development; Providing a website featuring information in the fields of drug discovery and development, biochemistry, biotechnology, medicines, diagnostics, and pharmaceuticals; Provision of scientific, medical, biotechnology, biomedical, vaccine and pharmaceutical information regarding drug discovery, pharmaceutical products, vaccines and clinical trials
The mark consists of an incomplete open circle which is partially bisected by four lines forming an open triangle and incomplete open triangle, where each of the four lines are connected by filled circles; the word "eikon" is immediately adjacent and over the word "therapeutics".
"THERAPEUTICS"

Trademark Events
Mar 5, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 4, 2024
Sou Extension 3 Granted
Mar 4, 2024
Sou Extension 3 Filed
Mar 4, 2024
Sou Teas Extension Received
Sep 26, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 22, 2023
Sou Extension 2 Granted
Sep 22, 2023
Sou Extension 2 Filed
Sep 22, 2023
Sou Teas Extension Received
Mar 22, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 20, 2023
Sou Extension 1 Granted
Mar 20, 2023
Sou Extension 1 Filed
Mar 20, 2023
Sou Teas Extension Received
Sep 27, 2022
Noa E-Mailed - Sou Required From Applicant
Aug 2, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 2, 2022
Published For Opposition
Jul 13, 2022
Notification Of Notice Of Publication E-Mailed
Jun 25, 2022
Approved For Pub - Principal Register
Jun 25, 2022
Examiner's Amendment Entered
Jun 25, 2022
Notification Of Examiners Amendment E-Mailed
Jun 25, 2022
Examiners Amendment E-Mailed
Jun 25, 2022
Examiners Amendment -Written
Jan 6, 2022
Notification Of Non-Final Action E-Mailed
Jan 6, 2022
Non-Final Action E-Mailed
Jan 6, 2022
Non-Final Action Written
Jan 5, 2022
Assigned To Examiner
Sep 13, 2021
Teas Change Of Correspondence Received
Sep 13, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 13, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 7, 2021
Notice Of Design Search Code E-Mailed
Aug 6, 2021
New Application Office Supplied Data Entered
May 7, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24